Home
Clinical Resources Search
PQI: Margetuximab-cmkb (MARGENZA®) Management

Margetuximab-cmkb (MARGENZA®) Management

Last Updated: July 5, 2023

By: Aisha Shokoya, BCOP, BCPS

About this PQI

The purpose of this PQI is to provide guidance for the management and treatment of HER2 positive, metastatic breast cancer using margetuximab-cmkb for patients who have received two or more lines of prior anti-HER2 regimens, one of which is in the metastatic setting.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Breast Cancer MARGENZA Margetuximab-cmkb

PQI

Frequently Searched

Supported by

Margetuximab-cmkb (MARGENZA®) Management

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Eflapegrastim-xnst (Rolvedon) for Chemotherapy-Induced Neutropenia

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (OGSIVEO®) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

PQI in Action: Abiraterone acetate (Yonsa®) Patient Selection and Management

PQI in Action: Enfortumab Vedotin-ejfv (Padcev®) and Pembrolizumab (Keytruda®) Management for Advanced or Metastatic Urothelial Carcinoma

S9 E7: A Haven of Healing

S9 E6: Healing Through Sound: A Breast Cancer Journey

S9 E5: Global Health, Cancer Survivorship, and Advancing Equity

S9 E4: Advancing Pharmacogenomics in Oncology

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Etoposide

S9 E6: Healing Through Sound: A Breast Cancer Journey

Abemaciclib

Tucatinib

Eribulin and Margetuximab

Eribulin and Margetuximab

PQI in Action: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Nirogacestat (Ogsiveo): Treatment Discussion Guide

Vorasidenib

Encorafenib and Binimetinib